ACADIA Pharmaceuticals EPS Diluted from Accounting Change (Quarterly) Trends

ACADIA Pharmaceuticals, Inc. (ACAD)

26.76 +0.47 (+1.79%) USD | NASDAQ | Jan 21, 16:00

26.65 -0.11 (-0.41%) Pre-Market: 09:09

View EPS Diluted from Accounting Change (Quarterly) for ACAD.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Accounting Change (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Accounting Change (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Accounting Change (Quarterly) Benchmarks

Start Trial

Amicus Therapeutics, Inc.	--
ANI Pharmaceuticals, Inc.	--
Catalyst Pharmaceuticals, Inc.	--
Regeneron Pharmaceuticals, Inc.	--
Puma Biotechnology, Inc.	--